UK Markets close in 43 mins

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
85.24+1.00 (+1.19%)
As of 10:47AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close84.24
Open84.82
Bid85.14 x 900
Ask85.15 x 2200
Day's range84.81 - 85.62
52-week range79.34 - 95.17
Volume904,645
Avg. volume2,487,830
Market cap191.006B
Beta (5Y monthly)0.53
PE ratio (TTM)19.69
EPS (TTM)4.33
Earnings dateN/A
Forward dividend & yield3.20 (3.66%)
Ex-dividend date04 Mar 2021
1y target est101.20
  • Globe Newswire

    Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer

    PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022. “I am delighted to welcome Cintia to our leadership team. She brings extensive commercial experience, including in cell and gene therapy, that will be key as we prepare to submit our first BLA for afami-cel this year, and buil

  • Zacks

    Ionis' (IONS) Eplontersen Gets Orphan Drug Tag From FDA

    The FDA bestows an Orphan Drug status to Ionis' (IONS) investigational medicine, eplontersen, for treating people living with transthyretin-mediated amyloidosis.

  • Motley Fool

    Novartis Hopes to Have Another COVID Therapy on the Way

    Novartis and Molecular Partners reported positive results for COVID-19 candidate ensovibep.